Welcome to our dedicated page for Huron Consul SEC filings (Ticker: HURN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Huron Consulting Group turns complex healthcare, higher-education, and commercial advisory projects into revenue isn’t easy. Footnotes on billable hours, goodwill from dozens of acquisitions, and variable compensation plans sprawl across hundreds of pages. If you’ve ever hunted through a 10-K for segment margins or waited on email alerts for a sudden 8-K, you know the challenge.
Stock Titan solves this problem. Our AI parses every new HURN disclosure the moment it hits EDGAR and serves you the essentials. Need the latest Huron Consulting Group quarterly earnings report 10-Q filing broken down by consulting practice? One click. Curious about Huron Consulting Group insider trading Form 4 transactions? Real-time dashboards show Huron Consulting Group Form 4 insider transactions real-time alongside price charts. We even tag sections so you can jump directly to revenue-recognition policies or human-capital metrics. In short, we make Huron Consulting Group SEC filings explained simply.
- Huron Consulting Group annual report 10-K simplified—see cash flow by practice area, backlog trends, and acquisition earn-outs.
- Huron Consulting Group proxy statement executive compensation—compare partner bonuses and equity grants to utilization rates.
- Huron Consulting Group 8-K material events explained—from new contract wins to leadership changes.
- Huron Consulting Group earnings report filing analysis—AI-generated narrative of quarter-over-quarter performance.
- Understanding Huron Consulting Group SEC documents with AI—contextual definitions replace jargon so you focus on decisions.
- Huron Consulting Group executive stock transactions Form 4—instant alerts when leaders buy or sell shares.
Whether you’re modeling revenue by segment, monitoring insider sentiment before material announcements, or evaluating acquisition strategy, our platform delivers the insights professionals seek—without the paperwork.
Form 4 shows that J. Ronald Dail, Chief Operating Officer of Huron Consulting Group Inc. (HURN), sold 1,421 shares of common stock on
The sale was executed automatically under a Rule 10b5-1 trading plan adopted on
Director Debra Zumwalt reported a sale of 170 shares of Huron Consulting Group Inc. (HURN) on
The sale was executed automatically under a Rule 10b5-1 trading plan that the reporting person adopted on
Ekta Singh-Bushell, a director of Huron Consulting Group Inc. (HURN), reported a sale of 126 shares of the company's common stock on
After the reported transaction the reporting person beneficially owned 15,341 shares, held directly. The Form 4 was signed by an attorney-in-fact and dated
Huron Consulting Group Inc. (HURN) director Hugh E. Sawyer III reported a routine sale of 136 shares of common stock on
Huron Consulting Group insider filed a Form 144 notifying a proposed sale of 1,421 common shares with an aggregate market value of $213,150. The shares are scheduled for sale on 10/03/2025 on NASDAQ. The filer acquired the shares on 03/01/2025 through restricted stock vesting and the shares were issued as compensation. The filing reports no sales by the same person in the past three months and includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
James H. Roth, a director of Huron Consulting Group Inc. (HURN), reported the automatic sale of 2,000 shares on 10/01/2025 under a Rule 10b5-1 trading plan adopted May 8, 2025. The sales were reported in three blocks: 1,026 shares at a weighted average within $145.18–$145.95, 478 shares within $146.18–$147.11, and 496 shares within $147.18–$147.90. Following these transactions the reporting person beneficially owns 39,304 shares directly and 3,855 shares indirectly through a family LLC. The form was signed by an attorney-in-fact on 10/03/2025.
John McCartney, a director of Huron Consulting Group Inc. (HURN), reported a sale of 500 shares of the issuer's common stock on 10/01/2025 at a reported price of $145.68 per share. The filing shows the sale occurred automatically under a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2024. After the transaction, Mr. McCartney beneficially owns 50,317 shares.
The Form 4 was signed by Hope Katz, Attorney-in-fact, on behalf of Mr. McCartney and dated 10/03/2025. The document is a routine Section 16 report disclosing an insider disposition executed per a pre-established plan; no derivative transactions, option exercises, or additional contextual financial metrics are provided in this filing.
Hugh E. Sawyer, a director of Huron Consulting Group Inc. (HURN), reported a sale of 400 shares of Huron common stock on 10/01/2025 at a price of $145.68 per share. The filing shows the sale was executed automatically under a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.
After the reported transaction, the reporting person beneficially owned 22,862 shares of Huron common stock. The Form 4 was submitted by an attorney-in-fact on behalf of Mr. Sawyer. No options, derivatives, or additional transactions are reported on this form.
Form 144 filed for Huron Consulting Group Inc. (HURN) reports a proposed sale of 136 common shares through Fidelity Brokerage Services with an aggregate market value of $19,981.12 and an approximate sale date of 10/02/2025. The filing states these 136 shares were acquired on 10/01/2025 upon restricted stock vesting from the issuer and payment is described as compensation. The issuer’s outstanding shares are listed as 17,306,887. The filing also discloses four prior sales by Hugh E. Sawyer in the past three months: 136 shares on 07/02/2025 for $18,592.56, 400 shares on 08/01/2025 for $51,644.00, 400 shares on 09/02/2025 for $54,484.00, and 400 shares on 10/01/2025 for $58,272.00.
Form 144 filed for Huron Consulting Group Inc. (HURN): An insider plans to sell 126 shares of common stock that vest as restricted compensation. The shares were acquired by vesting on 10/01/2025 and the filing lists an approximate sale date of 10/02/2025 through Fidelity Brokerage Services. The filing shows an aggregate market value of $18,511.92 for the proposed sale and reports 17,306,887 shares outstanding. The same person previously sold 126 shares on 08/14/2025 for $17,057.88. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.